NiSource CapEx decreased by 4.9% to $805.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 26.3%, from $637.30M to $805.20M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 10.9% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $431.10M | $494.70M | $545.20M | $450.10M | $466.90M | $606.00M | $680.10M | $557.10M | $604.80M | $723.70M | $760.20M | $589.50M | $629.80M | $634.70M | $760.00M | $637.30M | $658.20M | $640.50M | $846.30M | $805.20M |
| QoQ Change | — | +14.8% | +10.2% | -17.4% | +3.7% | +29.8% | +12.2% | -18.1% | +8.6% | +19.7% | +5.0% | -22.5% | +6.8% | +0.8% | +19.7% | -16.1% | +3.3% | -2.7% | +32.1% | -4.9% |
| YoY Change | — | — | — | — | +8.3% | +22.5% | +24.7% | +23.8% | +29.5% | +19.4% | +11.8% | +5.8% | +4.1% | -12.3% | -0.0% | +8.1% | +4.5% | +0.9% | +11.4% | +26.3% |